Press Releases

IP Resources Set to Unlock Value in the $237 Billion Intellectual Property Licensing Market

Download PDF

Growing IP Portfolio Includes Stem Cell, Cardiac, and 3D Display Technologies

LOS ANGELES, CA -- (MARKETWIRE) -- 01/07/13 -- IP Resources International, a wholly owned subsidiary of Hanover Portfolio Acquisitions, Inc., (OTCQB: HVPA), an intellectual property licensing and commercialization company, announced today that it is in discussions with multiple technology companies to further expand its growing intellectual property (IP) portfolio. IP Resources' strategy is to commercialize and monetize market-ready technologies to the benefit of its shareholders and technology partners.

IP Resources acquires rights primarily of market-ready technologies and products and works to monetize the intellectual property through joint ventures, and domestic and international sub-licensing in the largest and fastest growing global markets including Brazil, Russia, India, China and the European Union.

According to Intellectual Ventures, the majority of patent owners are not maximizing the value of their IP assets. IP Resources creates and unlocks value by licensing technologies from patent owners and monetizing these IP assets. IP has recently emerged as an important asset class among companies seeking to maintain a competitive advantage. Worldwide royalty and licensing fee receipts were approximately $237 billion in 2010 according to the International Monetary Fund (IMF).

"In addition to the technologies we have in our IP portfolio, we are currently in late-stage discussions with multiple technology companies to exclusively license or acquire very compelling technologies that have immediate market value and revenue potential for IP Resources. We're very excited about the prospects for our business and our ability to execute on multi-billion dollar IP opportunities," stated IP Resources Chairman and CEO, Alan Collier.

To date, the Company has in place three technology licensing, distribution and commercialization agreements for products and technologies that collectively address multi-billion dollar markets including:

  • Proprietary Stem Cell Technology Addressing $3.8 Billion Market
    IP Resources has an exclusive license agreement with American CryoStem Corp. to sub-license and to distribute certain stem cell-related IP in China and Brazil. According to BCC Research the global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

    The IP covers a proprietary stem cell technology platform that extracts body fat (adipose tissue) through a minimally invasive procedure, separates stem cells from the fat, and stores the stem cells for future use through cryogenic freezing. Adipose derived stem cells have the potential to transform into any one of a vast number of essential human cells for muscle, cartilage, bone, brain, heart, liver, pancreas and blood vessels.

  • Global CPR-Aid Medical Device Market
    The Company has an exclusive license agreement with CPAIR, Inc. ("CPaiR") to sub-license, market and distribute certain intellectual property on a worldwide basis outside of the United States. CPaiR is a device that enables anyone to administer CPR safely and effectively. The device addresses the entire global market for CPR training and associated devices. The American Heart Association states that 88% of cardiac arrests in the U.S. happen at home and if a person is called on to administer CPR in an emergency, the life saved is likely to be someone at home: a child, a spouse, a parent or a friend. CPaiR is designed for use at home, schools, retail and restaurant locations by anyone in an emergency situation. It may also be used by emergency medical professionals in ambulances and other medical settings.

    The CPaiR device consists of proprietary IP, which includes providing a clear, concise, audible voice prompt that guides the person administering CPR, providing accurate timing for chest compressions and breaths to enable optimal outcomes.

  • $13.2 Billion 3D Display Market
    IP Resources has a licensing and distribution agreement with Xtreme Electronics Systems, Inc. to market, sell, and to distribute certain intellectual property in certain territories. This agreement also covers IP Resources' exclusive rights to sell and market XES' 3D hardware and software to Microsoft Corporation or its affiliates. According to research firm NPD Display Search, the 3D display market is set to grow from $13.2 billion in revenue in 2011 to $67 billion in revenue in 2019 worldwide.

    The IP covered by the licensing and distribution agreement allows users to view an array of content with incredible clarity and coloration in 3D without glasses. 3D content can be viewed at up to 110-degree angles on devices, including smartphones, tablets, desktop monitors, flat screen TVs, and more. The display can be used in a range of applications, from consumer electronics to medical imaging.

About IP Resource International
IP Resources International, Inc. is an intellectual property management firm that specializes in the commercialization of compelling technologies through joint ventures and international licensing. The Company specializes in the commercialization of technologies within the healthcare, energy, consumer electronics, and internet industries.

Safe Harbor Statement
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Investor Relations Contact:
Mr. Andrew Haag
Managing Partner
Hampton Growth
Tel: 877.368.3566
E-Mail: Email Contact